DOTO Medicalsp. z o.o. in liquidationStatus: Entity active
Research and experimental development in natural sciences and engineering
KRS: 0001006044 NIP: 8943200107 REGON: 52384380200000
Overview
Registry date
2022-12-02
Share capital
$21,907.08
Activity description
Doto Medical is focused on the development of aptamer technology for targeted filtration of bodily fluids, specifically to remove cytokines and toxins from the blood of patients with chronic kidney disease, during transplantation, and in oncology treatments. The company aims to create filters that can be used with existing organ perfusion devices, dialyzers, and separators. Their products are designed to improve patient outcomes by selectively eliminating harmful molecules while preserving the integrity of other biological components.
Registered address
Ul. Rakowiecka 36, 02-532 Warszawa, Poland
Website
dotomedical.euWebsite active
Email
[email protected]Email address current
Industry
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Captor TherapeuticsS.A. | $5,543,104.77 | captortherapeutics.pl | |
| Progressp. z o.o. | $517,600.96 | progres.com.pl | |
| BioceltixS.A. | $492,206.18 | bioceltix.com/ | |
| Bulletprovesp. z o.o. | $46,389.14 | bulletprove.com | |
| Bio2materialssp. z o.o. | $5,559.37 | bio2materials.com | |
| Adapt-Esp. z o.o. | — | adapt-e.com | |
| BiocamS.A. | — | biocam.ai | |
| Biorenomésp. z o.o. | — | biorenome.pl | |
| Blancsp. z o.o. | — | blanc.pl/ | |
| Caslavinieri Advancements Interactivesp. z o.o. | — | caslavinieri.com |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Liquidation | Liquidation opened | 2025-12-23 |
Last updated: 2026-05-23